Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3427720
Max Phase: Preclinical
Molecular Formula: C64H100N24O13S
Molecular Weight: 1445.73
Molecule Type: Small molecule
Associated Items:
ID: ALA3427720
Max Phase: Preclinical
Molecular Formula: C64H100N24O13S
Molecular Weight: 1445.73
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCN(CC)c1ccc2cc(-n3cc(CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc4ccc(O)cc4)C(N)=O)nn3)c(=O)oc2c1
Standard InChI: InChI=1S/C64H100N24O13S/c1-5-87(6-2)40-20-18-38-33-49(61(100)101-50(38)34-40)88-35-39(85-86-88)19-25-52(91)78-42(13-9-28-74-62(68)69)55(94)77-36(3)54(93)79-43(12-7-8-27-65)56(95)80-44(14-10-29-75-63(70)71)57(96)81-45(15-11-30-76-64(72)73)58(97)83-47(26-31-102-4)60(99)82-46(23-24-51(66)90)59(98)84-48(53(67)92)32-37-16-21-41(89)22-17-37/h16-18,20-22,33-36,42-48,89H,5-15,19,23-32,65H2,1-4H3,(H2,66,90)(H2,67,92)(H,77,94)(H,78,91)(H,79,93)(H,80,95)(H,81,96)(H,82,99)(H,83,97)(H,84,98)(H4,68,69,74)(H4,70,71,75)(H4,72,73,76)/t36-,42-,43-,44-,45-,46-,47-,48-/m0/s1
Standard InChI Key: RJDFZCGUCBCSPU-VUSFATCJSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1445.73 | Molecular Weight (Monoisotopic): 1444.7622 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Ferreira SZ, Carneiro HC, Lara HA, Alves RB, Resende JM, Oliveira HM, Silva LM, Santos DA, Freitas RP.. (2015) Synthesis of a New Peptide-Coumarin Conjugate: A Potential Agent against Cryptococcosis., 6 (3): [PMID:25815145] [10.1021/ml500393q] |
Source(1):